THE FILTER DISC BLOOD COLLECTION METHOD ADAPTED FOR A MUMPS HAI SEROLOGIC SURVEY1

1964 ◽  
Vol 79 (3) ◽  
pp. 245-249
Author(s):  
ROBERT M. WORTH
2020 ◽  
Vol 5 (2) ◽  
pp. 363-369
Author(s):  
Theresa Madigan ◽  
Darci R Block ◽  
William A Carey ◽  
Bethany D Kaemingk ◽  
Robin Patel

Abstract Background Plasma ammonia is commonly measured in the diagnostic evaluation of hospitalized newborns, but reference values are not well defined. Methods We prospectively enrolled newborns admitted to the level III/IV neonatal intensive care unit and level II intermediate special care nursery from January 2017 to January 2018. Infants with inborn errors of metabolism or liver disease were excluded. Plasma ammonia concentrations were measured once within the first week of life and evaluated by sex, gestational age, timing of the draw, blood collection method, and type of nutrition. Reference intervals were calculated. Results 127 neonates were included; one third (34%) were term infants born at ≥37 weeks gestation, and two thirds (66%) were born preterm at <37 weeks gestation. Median plasma ammonia concentrations were 32 μmol/L (range <10 to 86 μmol/L). Median ammonia concentrations were higher among preterm compared to term infants (35 vs. 28 μmol/L, p = 0.0119), and term female compared to term male infants (34 vs. 26 μmol/L, p = 0.0228). There was no difference in median ammonia concentrations between female and male preterm infants, based on gestational age within the preterm group, timing of the blood draw, presence of hyperbilirubinemia, blood collection method, or type of nutritional intake. Conclusions Plasma ammonia concentrations among newborns are higher than the expected adult concentrations and may vary by gestational age and sex. Blood collection method, type of nutrition, hyperbilirubinemia, and timing of the draw do not impact concentrations. We propose a reference limit of ≤82 μmol/L for newborns less than one week of age.


2013 ◽  
Vol 12 (4) ◽  
pp. 1580-1590 ◽  
Author(s):  
Fatemeh Babaei ◽  
Rajkumar Ramalingam ◽  
Amy Tavendale ◽  
Yimin Liang ◽  
Leo So Kin Yan ◽  
...  

2012 ◽  
Vol 56 (4) ◽  
pp. 598-605 ◽  
Author(s):  
Vivek Jain ◽  
Teri Liegler ◽  
Jane Kabami ◽  
Gabriel Chamie ◽  
Tamara D. Clark ◽  
...  

Stem Cells ◽  
2005 ◽  
Vol 23 (3) ◽  
pp. 324-334 ◽  
Author(s):  
Rafael Bornstein ◽  
Aan I. Flores ◽  
M. Angeles Montalbán ◽  
Manuel J. del Rey ◽  
Javier de la Serna ◽  
...  

Zoo Biology ◽  
2015 ◽  
Vol 34 (5) ◽  
pp. 497-500 ◽  
Author(s):  
Yusuke Otaki ◽  
Nobuhide Kido ◽  
Tomoko Omiya ◽  
Kaori Ono ◽  
Miya Ueda ◽  
...  

1999 ◽  
Vol 41 (4) ◽  
pp. 239-242 ◽  
Author(s):  
Jane TOMIMORI-YAMASHITA ◽  
Thu H. NGUYEN ◽  
Solange M. MAEDA ◽  
Beatrice FLAGEUL ◽  
Osmar ROTTA ◽  
...  

The authors studied 70 leprosy patients and 20 normal individuals, comparing the traditional sera collection method and the finger prick blood with the conservation on filter paper for specific antibodies against the native phenolic glycolipid-I (PGL-I) from Mycobacterium leprae. The finger prick blood dried on filter paper was eluated in phosphate buffer saline (PBS) containing 0.5% gelatin. The classical method for native PGL-I was performed for these eluates, and compared with the antibody determination for sera. It was observed that there is a straight correlation comparing these two methods; although the titles found for the eluates were lower than those obtained for serology. This blood collection method could be useful for investigation of new leprosy cases in field, specially in contacts individuals.


2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S388-S388
Author(s):  
Richard B Clark ◽  
Ronald N Master ◽  
Hema Kapoor ◽  
Caixia Bi ◽  
Martin H Kroll ◽  
...  

Abstract Background The QuantiFERON-TB Gold Plus (QFT-Plus) test is an assay for detecting a cell-mediated immune response to M. tuberculosis (MTB). The assay measures the in vitro quantitative IFN-γ responses to MTB or control antigens in an incubated blood sample. There are 2 options for QFT-Plus blood collection. One option is a lithium-heparin transport tube with sample aliquots subsequently transferred to 4 QFT-Plus Blood Collection Tubes (1-tube QFT-Plus); the 2nd option is to directly collect the blood sample in 4 QFT-Plus collection tubes (4-tube QFT-Plus). In this study, we compared the indeterminate (IND) rates by the 2 blood collection methods to assess which method was superior. Methods For both blood collection methods, QFT-Plus ELISA testing was performed at various Quest Diagnostics sites as specified in the assay’s package insert. A retrospective data analysis of results for the above 2 blood processing methods was conducted. Also, we evaluated the rates of IND results in follow up blood collections. Statistical analyses were performed by the proportion test. Results In 2019, the IND result rate for greater than an 1.8 million 1-tube QFT-Plus draws was less than 1% whereas, the IND result rate for 0.3 million 4-tube draws was 4% This difference was significant. The overall MTB positive rate was 7% for the 1-tube method and 6% for the 4-tube method. Within a one-month interval following an initial blood collection event, 464 patients with an original IND result had a 2nd blood sample collected and tested. Only 35% of the 2nd blood collection events produced an IND result, with 52% of the 2nd sample results reporting as negative and 13% were positive. Conclusion This study found that the 1-tube QFT-Plus collection method reduces the IND rates by 4-fold compared to the observed rate in the 4-tube process. Additionally, two thirds of patients with an initial IND result resolved to either a positive or a negative result when retested within 1 month. Disclosures All Authors: No reported disclosures


Sign in / Sign up

Export Citation Format

Share Document